Introducing
Avicena Sentinel
Fast, Accurate, Affordable, and Scalable Pathogen Screening
The most scalable rapid molecular diagnostics platform in the world, offering a unique surge capability of up to 100,000 tests daily.
Next-Generation Molecular Diagnostics
The Avicena Sentinel is the world’s most scalable rapid molecular diagnostics platform.
Available in two versions, the Sentinel ULTRA and Sentinel Mini cater to diverse testing needs, making it economically viable for both low and high-volume scenarios.
With accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and affordability, while preserving the capability to screen for multiple pathogens simultaneously.
Effortless Saliva Sample Collection
Quick Saliva Sample Collection
Simply swab your mouth with our microswab to gather the optimal saliva volume.
Secure in Barcoded Sample Tube
Secure the swab in the provided barcode-labeled sample tube that contains a stabilising buffer solution.
The Sentinel Platform
Sentinel Mini
Surge capacity up to 384 hourly
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting
Sentinel ULTRA V3
Surge capacity up to 100,000 daily
Up to 10x faster than PCR
Continuous Flow Processing
Fully Automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting
The Future of Biosecurity
The flexible Sentinel system can rapidly adapt to test for current and emerging pathogen threats.
Human Biosecurity
Emerging Threats
Lumpy Skin Disease
Japanese Encephalitis Virus
Monkeypox
Zika Virus
Dengue
Malaria
Bioengineered Pathogens
Blood Banks
HIV
Hepatitis B
Hepatitis C
Antibiotic Resistant Pathogens
Drug-Resistant Tuberculosis
MRSA
VRE
Pseudomonas
Acinetobacter
Influenza
Human & Zoonotic influenza
Emerging Pandemic Flu Threats
Animal Biosecurity
Cattle
Lumpy Skin Disease
Foot & Mouth Disease
Brucellosis
Equine
Herpesvirus
Nipah
Hendra
Pigs
African Swine Fever
Swine Flu
Birds
Avian Flu
Psittacosis
Enforce your First Line of Defence
Rapid detection, reporting and response to disease outbreaks is the first line of defence.
Contact our team to learn what an effective and rapid implementation looks like.
Scientific Publications
Dewhurst RE, et al. 2022.Nature, Scientific Reports. Access here: DOI.
TGA Authorised1
Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.
CE-Marked Chemistry
CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.
Patent-Pending
Avicena holds several patent pending innovations that enable our groundbreaking performance.
Intended Use
The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.